InsidersTradesSigma
Explore the detailed record of transactions filed by Krishnan Rajesh, Chief Technology Officer. Insider active across 1 companies, notably Oncternal Therapeutics, Inc.. In total, 2 disclosures have been published. The latest transaction was disclosed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Rajesh Krishnan is Chief Technology Officer at Oncternal Therapeutics, Inc. He is responsible for the technical direction of the company, overseeing the development of new technologies and products. His expertise is essential for innovation and the success of Oncternal Therapeutics.